Cargando…

Complexity of Human Antibody Response to Dengue Virus: Implication for Vaccine Development

The four serotypes of dengue virus (DENV) are the leading cause of arboviral diseases in humans. Decades of efforts have made remarkable progress in dengue vaccine development. Despite the first dengue vaccine (dengvaxia from Sanofi Pasteur), a live-attenuated tetravalent chimeric yellow fever-dengu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsai, Wen-Yang, Lin, Hong-En, Wang, Wei-Kung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5517401/ https://www.ncbi.nlm.nih.gov/pubmed/28775720 http://dx.doi.org/10.3389/fmicb.2017.01372

Ejemplares similares

Human antibody response to dengue virus: implications for dengue vaccine design
por: Moi, Meng Ling, et al.
Publicado: (2016)

The Complexity of a Dengue Vaccine: A Review of the Human Antibody Response
por: Flipse, Jacky, et al.
Publicado: (2015)

Potent Neutralization Ability of a Human Monoclonal Antibody Against Serotype 1 Dengue Virus
por: Lu, Jiansheng, et al.
Publicado: (2018)

Epitope resurfacing on dengue virus-like particle vaccine preparation to induce broad neutralizing antibody
por: Shen, Wen-Fan, et al.
Publicado: (2018)

The Human Antibody Response to Dengue Virus Infection
por: Wahala, Wahala M. P. B., et al.
Publicado: (2011)

Analysis of Epitopes on Dengue Virus Envelope Protein Recognized by Monoclonal Antibodies and Polyclonal Human Sera by a High Throughput Assay
por: Lin, Hong-En, et al.
Publicado: (2012)

Antibody-Dependent Enhancement: A Challenge for Developing a Safe Dengue Vaccine
por: Shukla, Rahul, et al.
Publicado: (2020)

Screening for immune response against Dengue virus in Vietnamese non-human primates: implications for vaccine developers
por: Lazo Vázquez, Laura, et al.
Publicado: (2017)

Anti-Idiotypic Antibodies Specific to prM Monoantibody Prevent Antibody Dependent Enhancement of Dengue Virus Infection
por: Wang, Miao, et al.
Publicado: (2017)

Challenges to the development of vaccines to hepatitis C virus that elicit neutralizing antibodies
por: Drummer, Heidi E.
Publicado: (2014)

Impact of Intrahost NS5 Nucleotide Variations on Dengue Virus Replication
por: Cheng, Dayna, et al.
Publicado: (2022)

In-Depth Analysis of the Antibody Response of Individuals Exposed to Primary Dengue Virus Infection
por: de Alwis, Ruklanthi, et al.
Publicado: (2011)

Defeat Dengue and Zika Viruses With a One-Two Punch of Vaccine and Vector Blockade
por: Sun, Jin, et al.
Publicado: (2020)

Development of a Novel Assay to Assess the Avidity of Dengue Virus-Specific Antibodies Elicited in Response to a Tetravalent Dengue Vaccine
por: Tsuji, Isamu, et al.
Publicado: (2021)

Correction: In-Depth Analysis of the Antibody Response of Individuals Exposed to Primary Dengue Virus Infection
por: de Alwis, Ruklanthi, et al.
Publicado: (2011)

Asunaprevir Evokes Hepatocytes Innate Immunity to Restrict the Replication of Hepatitis C and Dengue Virus
por: Tsai, Wei-Lun, et al.
Publicado: (2017)

Zika Virus Induced More Severe Inflammatory Response Than Dengue Virus in Chicken Embryonic Livers
por: Zhang, Zongyi, et al.
Publicado: (2019)

The Complexity of Antibody-Dependent Enhancement of Dengue Virus Infection
por: Guzman, Maria G., et al.
Publicado: (2010)

Recent Insights Into the Molecular Mechanism of Toll-Like Receptor Response to Dengue Virus Infection
por: Kayesh, Mohammad Enamul Hoque, et al.
Publicado: (2021)

microRNAs, the Link Between Dengue Virus and the Host Genome
por: Su, Yinghua, et al.
Publicado: (2021)

SUMOylation Is Essential for Dengue Virus Replication and Transmission in the Mosquito Aedes aegypti
por: Weng, Shih-Che, et al.
Publicado: (2022)

Vaccine Development against Zoonotic Hepatitis E Virus: Open Questions and Remaining Challenges
por: Nan, Yuchen, et al.
Publicado: (2018)

Componential usage patterns in dengue 4 viruses reveal their better evolutionary adaptation to humans
por: Li, Gun, et al.
Publicado: (2022)

Assessment of the Risk of Severe Dengue Using Intrahost Viral Population in Dengue Virus Serotype 2 Patients via Machine Learning
por: Hung, Su-Jhen, et al.
Publicado: (2022)

Dissecting the human serum antibody response to secondary dengue virus infections
por: Patel, Bhumi, et al.
Publicado: (2017)

Antigen-Specific Acquired Immunity in Human Brucellosis: Implications for Diagnosis, Prognosis, and Vaccine Development
por: Cannella, Anthony P., et al.
Publicado: (2012)

HELZ2 Is an IFN Effector Mediating Suppression of Dengue Virus
por: Fusco, Dahlene N., et al.
Publicado: (2017)

Dengue Virus Glycosylation: What Do We Know?
por: Yap, Sally S. L., et al.
Publicado: (2017)

Prevention and Control Strategies to Counter Dengue Virus Infection
por: Rather, Irfan A., et al.
Publicado: (2017)

Mobilization and Activation of the Innate Immune Response to Dengue Virus
por: King, Christine A., et al.
Publicado: (2020)

Adeno-associated virus receptor complexes and implications for adeno-associated virus immune neutralization
por: Large, Edward E., et al.
Publicado: (2023)

Genomic characterization of dengue virus serotype 2 during dengue outbreak and endemics in Hangzhou, Zhejiang (2017–2019)
por: Sun, Hua, et al.
Publicado: (2023)

Characterization and epitope mapping of Dengue virus type 1 specific monoclonal antibodies
por: Chen, Wen-Hung, et al.
Publicado: (2017)

Seroprevalence of dengue virus in two districts of Kaohsiung City after the largest dengue outbreak in Taiwan since World War II
por: Tsai, Jih-Jin, et al.
Publicado: (2018)

A Coupled Mathematical Model of the Intracellular Replication of Dengue Virus and the Host Cell Immune Response to Infection
por: Zitzmann, Carolin, et al.
Publicado: (2020)

C-Terminal Helical Domains of Dengue Virus Type 4 E Protein Affect the Expression/Stability of prM Protein and Conformation of prM and E Proteins
por: Tsai, Wen-Yang, et al.
Publicado: (2012)

Immune Responses to Dengue and Zika Viruses—Guidance for T Cell Vaccine Development
por: Roth, Claude, et al.
Publicado: (2018)

T Cell Responses to Nonstructural Protein 3 Distinguish Infections by Dengue and Zika Viruses
por: Herrera, Bobby Brooke, et al.
Publicado: (2018)

Vaccination With a Single Consensus Envelope Protein Ectodomain Sequence Administered in a Heterologous Regimen Induces Tetravalent Immune Responses and Protection Against Dengue Viruses in Mice
por: Wang, Ran, et al.
Publicado: (2019)

Codon Usage and Adenovirus Fitness: Implications for Vaccine Development
por: Giménez-Roig, Judit, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j5u9a5o1fnif30rlphd511hfeq